Learn AI, Data Science & Business — Earn Certificates That Get You Hired
Get 20% off all career paths from fullstack to AI
Overview
Build a Learning Habit
Download Class Central's free printable study calendar
Download for Free
In this 10-minute educational video, Dr. Stefania Morganti from Dana-Farber Cancer Institute's Breast Oncology Program explains the role of circulating tumor DNA (ctDNA) in detecting minimal residual disease in early stage breast cancer patients. Learn about this important diagnostic tool and how it's being utilized to improve treatment outcomes and patient monitoring in early breast cancer cases.
Syllabus
Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute
Taught by
Dana-Farber Cancer Institute